Açıklama

Summary of preclinical and clinical evidence on exosome-based therapies for hair regeneration, categorized by source, delivery method, and outcomes.

Figure 2

Diagram

Source Paper

A Scoping Review of Exosome Delivery Applications in Hair Loss.

Cureus (2025)

PMID: 40276450

DOI: 10.7759/cureus.81152

Cite This Figure

![Figure 2: Summary of preclinical and clinical evidence on exosome-based therapies for hair regeneration, categorized by source, delivery method, and outcomes.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12020662/bin/cureus-0017-00000081152-i02.jpg)

> Source: Sarah Schaffer et al. "A Scoping Review of Exosome Delivery Applications in Hair Loss.." *Cureus*, 2025. PMID: [40276450](https://pubmed.ncbi.nlm.nih.gov/40276450/)

<figure>
  <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12020662/bin/cureus-0017-00000081152-i02.jpg" alt="Summary of preclinical and clinical evidence on exosome-based therapies for hair regeneration, categorized by source, delivery method, and outcomes." />
  <figcaption>Figure 2. Summary of preclinical and clinical evidence on exosome-based therapies for hair regeneration, categorized by source, delivery method, and outcomes.<br>  Source: Sarah Schaffer et al. "A Scoping Review of Exosome Delivery Applications in Hair Loss.." <em>Cureus</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40276450/">40276450</a></figcaption>
</figure>